Depression in Children and Adolescents: Screening
Release Date: February 2016
|Adolescents aged 12 to 18 years|
The USPSTF recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.
|The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.|
|Children aged 11 years or younger|
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged 11 years or younger.
|The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.|
Related Information for Consumers
Internet Citation: Final Update Summary: Depression in Children and Adolescents: Screening. U.S. Preventive Services Task Force. September 2016.